VAERS reports by lot

Pfizer Pneumococcal lot FJ2604: VAERS reports

29 VAERS reports list lot FJ2604 as a Pfizer Pneumococcal vaccine, received between 2022-02-15 and 2023-03-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
3%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5254%
General / Systemic (non-local)1111%
Neurological1010%
Musculoskeletal99%
Dermatological (non-injection-site)55%
Cardiac / Cardiovascular33%
Allergic / Anaphylactic33%
Psychiatric / Neuropsychiatric33%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas10
Georgia4
New York2
Florida2
Connecticut2
Tennessee1
Alabama1
Utah1
New Hampshire1
Oklahoma1
Puerto Rico1
New Jersey1

Reports by month received

2022-022
2022-032
2022-042
2022-053
2022-061
2022-074
2022-083
2022-092
2022-102
2022-112
2022-122
2023-012
2023-021
2023-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.